New York State Common Retirement Fund
MACK

New York State Common Retirement Fund’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

New York State Common Retirement Fund’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,287
Closed -$19K – 3446
2024
Q1 		$19K Hold
1,287
– – ﹤0.01% 3148
2023
Q4 		$17.3K Sell
1,287
-6,920
-84% -$87.5K ﹤0.01% 3164
2023
Q3 		$101K Buy
8,207
+107
+1% +$1.3K ﹤0.01% 2716
2023
Q2 		$99.6K Buy
+8,100
New +$101K ﹤0.01% 2832
2018
Q2 		– Sell
-19,436
Closed -$123K – 3309
2018
Q1 		$123K Hold
19,436
– – ﹤0.01% 2909
2017
Q4 		$157K Hold
19,436
– – ﹤0.01% 2859
2017
Q3 		$222K Sell
19,436
-2
-0% -$21 ﹤0.01% 2723
2017
Q2 		$190K Sell
19,438
-13,615
-41% -$278K ﹤0.01% 2868
2017
Q1 		$801K Hold
33,053
– – ﹤0.01% 2150
2016
Q4 		$1.06M Hold
33,053
– – ﹤0.01% 2009
2016
Q3 		$1.65M Buy
33,053
+5,186
+19% +$215K ﹤0.01% 1753
2016
Q2 		$1.18M Hold
27,867
– – ﹤0.01% 1885
2016
Q1 		$1.83M Hold
27,867
– – ﹤0.01% 1641
2015
Q4 		$1.73M Buy
27,867
+6,448
+30% +$454K ﹤0.01% 1674
2015
Q3 		$1.43M Buy
21,419
+3,129
+17% +$255K ﹤0.01% 1754
2015
Q2 		$1.78M Buy
18,290
+11,707
+178% +$1.11M ﹤0.01% 1903
2015
Q1 		$615K Sell
6,583
-3,931
-37% -$335K ﹤0.01% 1989
2014
Q4 		$935K Sell
10,514
-26,650
-72% -$1.94M ﹤0.01% 1846
2014
Q3 		$2.57M Hold
37,164
– – ﹤0.01% 1502
2014
Q2 		$2.13M Buy
+37,164
New +$1.89M ﹤0.01% 1636

Other funds holding MACK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

New York State Common Retirement Fund's MACK Position: Q2 2024 in Review

New York State Common Retirement Fund sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 1,287 shares — an estimated $19K sold.

New York State Common Retirement Fund first reported a position in MACK in Q2 2014 and held it in 20 quarters. The position peaked at $2.57M in Q3 2014. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.

  • New York State Common Retirement Fund reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,287 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $19K.
  • New York State Common Retirement Fund first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2014 and held it in 20 quarters.
  • New York State Common Retirement Fund's Merrimack Pharmaceuticals, Inc. position peaked at $2.57M in Q3 2014.
  • 12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.

Based on New York State Common Retirement Fund's 13F filing for Q2 2024, filed 31 Jul 2024.